Search results
Is GSK an Attractive Drug Stock to Add to Your Portfolio Now?
Zacks via Yahoo News· 1 week agoGSK plc GSK boasts a diversified base and presence in different geographical areas. The spin-off of...
Gilead (GILD) Loses 17.6% YTD: How Should You Play the Stock?
Zacks via Yahoo News· 1 week agoWhile Gilead (GILD) has been reeling under pressure year to date due to pipeline setbacks, holding...
GSK Buys Flu, COVID mRNA Jab Rights From Partner CureVac
Zacks via Yahoo News· 2 weeks agoGSK revamps its existing collaboration deal with partner CureVac, converting it from a collaboration...
Biotech Stock Roundup: GSK, CVAC Revise Agreement, Updates From MRNA, RNAC & More
Zacks via Yahoo News· 2 weeks agoIt was a regular week for the biotech sector with quite a few important pipeline and regulatory...
CHMP Endorses Moderna's (MRNA) mRNA-based RSV Vaccine
Zacks via Yahoo News· 2 weeks agoModerna MRNA announced that the European Medicines Agency's (EMA) Committee for Medicinal Products...
Top Stock Reports for Chevron, Amgen & Philip Morris
Zacks via Yahoo News· 3 weeks agoToday's Research Daily features new research reports on 16 major stocks, including Chevron Corporation (CVX), Amgen Inc. (AMGN) and Philip Morris...
GSK's Filing for Expanded Use of Jemperli Gets EMA Acceptance
Zacks via Yahoo News· 3 weeks agoThe European Medicines Agency accepts GSK's application for the expanded use of Jemperli plus...
Gilead (GILD) Up as Twice-Yearly HIV Shot Prevents Infection
Zacks via Yahoo News· 4 weeks agoGilead's (GILD) twice-yearly, subcutaneous lenacapavir has demonstrated its potential as a new tool...
GSK's RSV Vaccine Arexvy Gets FDA Nod for Adults 50-59 Years
Zacks via Yahoo News· 1 month agoGSK GSK announced that the FDA has approved the expanded use of its respiratory syncytial virus...
J&J (JNJ) Seeks Expanded Use of HIV Drug in US and Europe
Zacks via Yahoo News· 1 month agoJohnson & Johnson JNJ announced that it has submitted a supplemental new drug application (sNDA)...